US2002085980A1PendingUtilityA1
Oral care product comprising a mutan binding domain
Est. expiryOct 25, 2016(expired)· nominal 20-yr term from priority
Inventors:Claus Crone Fuglsang
C12Y 302/01011A61Q 11/00C12N 9/2402C12Y 302/01084C07K 2319/00A61K 8/64A61K 8/66A61K 38/00C12N 9/20
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a polypeptide hybrid containing an amino acid sequence with binding affinity for mutan, the amino acid sequence being bound to an active component useful for oral care purposes; an oral care composition comprising a mutan binding domain; an oral care product comprising such an oral care composition of the invention; and finally the use of a mutan binding polypeptide hybrid or a single unit MBD for oral care purposes, including preventing dental plaque formation and/or removal of existing dental plaque.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A polypeptide hybrid comprising an amino acid sequence with binding affinity for mutan, said amino acid sequence being bound to an active component useful for oral care purposes.
2 . The polypeptide hybrid of claim 1 , wherein the active component is an anti-plaque, anti-stain or anti-microbial agent.
3 . The polypeptide hybrid of claim 1 , wherein the active component is an enzyme selected from the group consisting of oxidases, peroxidases, proteases, lipases, glucosidases, lipases, esterases, deaminases, ureases and polysaccharide hydrolases.
4 . The polypeptide hybrid of claim 3 , which polypeptide is bound to an enzyme with glycosidase activity.
5 . An oral care composition comprising a mutan binding domain (MBD) hybrid or single unit MBD and further ingredients conventionally used in oral care compositions.
6 . The oral care composition of claim 5 , wherein the MBD hybrid is a polypeptide hybrid according to claim 1 .
7 . An oral care product comprising an oral care composition of claim 5 .
8 . The oral care product of claim 7 , being a dentifrice.
9 . A hybrid comprising:
(a) an amino acid sequence which has binding affinity for mutan and which lacks a functional catalytic domain of a mutanase, linked to (b) an enzyme selected from the group consisting of deaminases, esterases, glucosidases, lipases, oxidases, peroxidases, polysaccharide hydrolases, proteases, and ureases.
10 . The hybrid of claim 9 , wherein the enzyme is a glycosidase.
11 . An oral care composition comprising (a) a hybrid of claim 9 or a single unit mutan binding domain and (b) further ingredients conventionally used in oral care compositions.
12 . An oral care product comprising an oral care composition of claim 11 .
13 . The oral care product of claim 12 , which is a dentifrice.Join the waitlist — get patent alerts
Track US2002085980A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.